NEWS
From pupil to full-time employee
Our school collaboration project has opened unexpected doors for Eivind.
New political paper: Action Plan for Clinical Studies
Norwegian government to double the number of clinical studies.
Dehns acquires Norwegian office
Dehns acquires Norwegian Intellectual Property consultancy Leogriff.
New clinical study in ovarian cancer
Ultimovacs has announced a new clinical study targeted at patients with ovarian cancer.
Landmark public-private agreement for precision cancer medicine
CONNECT is a completely new public-private collaboration in cancer precision medicine.
Oslo Cancer Cluster’s highlights 2020
Read a selection of our news from 2020.
Top news 2020 from Oslo Cancer Cluster's members
Read the top news from 2020 from a few of our members.
Positive results from Targovax’s skin cancer study
Update from Targovax on melanoma study shows responses in 7 of 20 patients.
Cancer drugs being tested to treat Covid-19
BerGenBio is testing the company’s cancer medicine as a treatment for Covid-19.
